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Abstract
Despite the apparent and well-known toxic effects of carbon monoxide (CO), studies on the intriguing
biological roles of this molecule are rapidly emerging. Recent investigations have brought to the
limelight various physiological effects of CO which include, among others, vasorelaxation and
inhibition of organ rejection after transplantation. The importance of CO in biology can be compared
with another gas, nitric oxide (NO), an essential and ubiquitous signalling molecule. This parallelism led
to the tantalising concept of using CO for therapeutic purposes wherein compounds that transport and
deliver this gas to a target tissue would clearly facilitate both the clinical feasibility and the specificity of
CO therapy. Sodium boranocarbonate, Na[H3 BCO2H] (1) was the first water-soluble and
non-transition metal containing CO-releasing molecule (CO-RM) to be identified. In order to tune the
rate of CO release, we modified 1 and synthesised and characterized various derivatives which release
CO under physiological conditions but at rates different from the parent compound 1. The synthesis,
structure and CO-releasing properties of ester and amide derivatives of 1 will be presented together with
some biological studies carried out with a selection of the compounds. 
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Abstract: Despite the apparent and well-known toxic effects of carbon monoxide (CO), studies on the intriguing
biological roles of this molecule are rapidly emerging. Recent investigations have brought to the limelight various
physiological effects of CO which include, among others, vasorelaxation and inhibition of organ rejection after
transplantation. The importance of CO in biology can be compared with another gas, nitric oxide (NO), an essen-
tial and ubiquitous signalling molecule. This parallelism led to the tantalising concept of using CO for therapeutic
purposes wherein compounds that transport and deliver this gas to a target tissue would clearly facilitate both
the clinical feasibility and the specificity of CO therapy. Sodium boranocarbonate, Na[H
3
BCO
2
H] (1) was the first
water-soluble and non-transition metal containing CO-releasing molecule (CO-RM) to be identified. In order to
tune the rate of CO release, we modified 1 and synthesised and characterized various derivatives which release
CO under physiological conditions but at rates different from the parent compound 1. The synthesis, structure and
CO-releasing properties of ester and amide derivatives of 1 will be presented together with some biological studies
carried out with a selection of the compounds.
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intense research around the biological and
medicinal importance of NO culminated
with the Nobel Prize in Medicine awarded
to scientists who discovered its physiologi-
cal function.
The situation is distinctly different in
the case of carbon monoxide (CO). The
toxic effect of CO gas is coherently typi-
fied at biochemical levels by the high affin-
ity for hemoglobin and cytochromes, which
are both heme-dependent proteins essential
for life. Only about ten years ago it became
clear that CO possesses, like NO, versa-
tile properties as a signalling mediator.
[3,4]
Beside being a potent vasodilator, CO can
exert anti-inflammatory, anti-apoptotic
and anti-proliferative effects to name just
a few of its pharmacological actions (Fig.
1).
[5]
With the emerging evidence that small
amounts of CO produced by the organism
is a key element in life processes, scientists
began to search for compounds capable of
releasing CO at specific sites with a con-
trollable and tuneable rate.
[6]
Compared to
NO-releasing drugs, the task of developing
CO carriers as pharmaceuticals is much
more challenging since CO is a very stable
molecule which does not readily and re-
versibly react with substrates but needs to
be incorporated in usually strong additional
bonds. The availability of ‘CO-releasing
molecules’ (CO-RMs) that are compatible
with a physiological environment not only
provides excellent perspectives for biologi-
cal or medicinal purposes but has also a
great impact on organometallic chemistry.
The immediate choice for compounds to be
utilized as CO-RMs is carbonyl-complexes,
which biochemical properties and biologi-
cal effects have been studied but there are
concerns about their solubility, stability and
the fact that they contain transition metals
which may or may not come as disadvan-
tages.
[6−8]
In the course of our studies for the
aqueous syntheses of
99m
Tc complexes, we
have found that sodium boranocarbonate,
Na[H
3
BCO
2
H] (1) releases CO with a rate
that is pH- and temperature-dependent.
[9]
This makes it a suitable molecule to carry
‘bound’ CO to target organs and to release
CO slowly. To further influence the rate of
CO release, we have now prepared various
amide and ester derivatives of 1. These de-
rivatives can be considered as ‘pro-drugs’
of CO-RMs whilst having the potential to
carry the molecule to specific sites in cells
or organisms.
[10]
Results and Discussion
The basic structure and some of the
prepared derivatives are presented in the
Scheme. The pK
a
values of 1 are compara-
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Introduction
Some twenty years ago, the reputation of
nitric oxide (NO) started to shift from a
noxious, polluting gas to a vital molecule
as a messenger in processes essential for
almost all living organisms including hu-
mans.
[1,2]
As a consequence, in 1992 the
prestigious journal Science proclaimed NO
‘molecule of the year’. In retrospective, it
does not come as a surprise that in 1998 the
doi:10.2533/chimia.2008.277
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ble to carbonic acid (hence the name). The
second pK
a
is difficult to determine since
protonation of 1 leads to irreversible cleav-
age of water and subsequent CO release.The
derivatization of 1 is also difficult, since the
hydrides, despite being bound rather stably,
are somewhat prone to hydrolysis or sub-
stitution. The reaction with alcohols such
as ethanol overnight led to almost quan-
titative yield to the corresponding ethyl-
ester Na[H
3
BCO
2
Et] (2) (Scheme), whose
structure could be confirmed by X-ray
analysis (Fig. 2). As encountered with all
presented compounds, crystallization was
only possible when encapsulating the Na
+
in 18-crown-6. Although esters are usually
only reacting very slowly with amines, we
found that 2 reacted at a reasonable rate
with primary and secondary amines to form
the corresponding amides. Along this syn-
thetic route, we have prepared the amides
with morpholine Na[H
3
BCO(morph)]
(3), glycine Na[H
3
BCO(gly)] (4), his-
tamine Na[H
3
BCO(hist)] (5) and
Na
2
[{H
3
BCO}
2
(en)] (6) with ethylene-di-
amine containing two molecules of 1 bound
to each terminal amine. A number of further
derivatives could be prepared implying that
the strategy is general and can also be ap-
plied to other potential linking groups. All
compounds are stable white solids which
could be fully characterized, some of them
by X-ray structure analysis.
In an earlier work, we studied the rate of
CO release of 1 under physiological condi-
tions and at 37 °C by means of a myoglobin
(Mb) assay.
[10]
Upon binding of CO to Mb,
the spectrum changes substantially and
rates can be determined. We found that the
rate of CO release showed a very steep pH
dependence with t
1/2
being 2.5 min at pH =
5.5, 7.1 min at pH = 7.0 and 21 min at pH
= 7.4, respectively. We studied CO release
with the newly prepared amide derivatives
by a gas chromatograph equipped with ther-
mal conductivity detector (GC-TCD) and
by
11
B and
1
H NMR experiments. Since
the release of CO requests two consecu-
tive steps, (first hydrolysis of the amide to
1 and then conversion of 1 to CO and some
borate products), we expected a decrease
of the overall rate. A typical time course
of the amount of CO as a function of time
determined by GC-TCD for compound 4
is shown in Fig. 3. It is obvious that the
strong pH-dependence is maintained. The
observed t
1/2
are now approximately 60 min
at pH = 6.8, 150 min at pH = 7.4 and 400
min at pH = 8.0, respectively. The corre-
sponding time courses for compounds 3−6
are very comparable and do not seem to be
significantly dependent on the nature of the
amide. It is clear that the elucidation of the
mechanism has to give an insight in the dif-
ferent mechanistic steps but the qualitative
numbers given above clearly demonstrate
the delay in CO release.
We would like to emphasize the differ-
ence between amides of carboxylic acids,
which essentially do not hydrolyse under
physiological conditions. The peptide bond
is extremely stable whereas the amides 3−6
decompose on a comparably short time
scale. This might point to a mechanism
different from acid-catalysed amide bond
cleavage.
Besides the quantification of released
CO, decomposition can also be followed by
1
H and
11
B NMR spectroscopy. During the
reaction, the
11
B signal of 3 and of 1 are the
only sharp signals to be observed by NMR.
Fig. 1. The multiple
pharmacological
effects of CO as a
signalling mediator in
living systems
Scheme. Pathway to ‘activated’ ester 2 and
subsequent reaction i) with amines leading to
the corresponding amides 3–6 of 1
Fig. 2. X-ray structures of the starting material 2
and the corresponding morpholino-amide 3
Fig. 3. CO release as a function of time for Na[H
3
BCO(gly)] (4) at pH 6.8. The amount of CO was
determined by GC-TCD
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All subsequent decomposition products
display only very broad unresolved bumps,
probably due to the presence of ill-defined
borates and/or borato-hydrides.
11
B NMR
spectra are given in Fig. 4. After 2 min, the
two signals of 1 and 3 reach a certain ratio
which is kept constant up to 24 h.
The same observations can be made in
the
1
H NMR spectra. All compounds com-
prising the ‘H
3
B’ moiety showed a nice
quartet centred around 0.6 ppm. The con-
version of 3 → 1 resulted in two clearly dis-
tinguishable sets of signals, indicative for
1 and 3 and decreasing with the same rate
the corresponding signals in the
11
B NMR
spectra. A corresponding spectrum is also
shown in Fig. 4.
According to our experimental results
and at a first glance, the mechanism of CO
release consists in amide hydrolysis and
subsequent protonation of 1 with release
of water to form highly reactive H
3
BCO,
which then decomposes to CO and borato-
hydrides. The deduction of single rate con-
stants from kinetic measurements is cur-
rently under investigation. Preliminary re-
sults indicate that the mechanism does not
consist of irreversible forward steps only
but that H
3
BCO in particular may hydro-
lyse back to 1 with a rate comparable to its
decomposition. Unambiguous elucidation
of the kinetic results is under way.
In conclusion, we have shown that the
half-life of CO release of the newly pre-
pared derivatives of boranocarbonate 1 can
be fine-tuned by the introduction of func-
tionalities at the carboxylic group. This also
implies that the model amines selected for
this study can be replaced by some meta-
bolically active targeting functions allow-
ing the CO-RM to be channelled to specific
sites in living organism where it needs to
exert its action. It can also be assumed that
these derivatives not only find applications
as CO-RMs in biology but also in other
areas such as the synthesis of carbonyl
complexes directly from water.
Acknowledgments
The authors thank the University of Zurich
and hemoCORM Ltd. UK for ﬁnancial support.
Received: February 25, 2008
[1] M. A. Gillman, F. J. Lichtigfeld, Nature
1994, 367, 28.
[2] A. R. Butler, D. L. H. Williams, Chem.
Soc. Rev. 1993, 22, 233.
[3] R. Motterlini, B. E. Mann, T. R. Johnson,
J. E. Clark, R. Foresti, C. J. Green, Curr.
Pharm. Design 2003, 9, 2525.
[4] T. R. Johnson, B. E. Mann, J. E. Clark, R.
Foresti, C. J. Green, R. Motterlini, Angew.
Chem., Int. Ed. 2003, 42, 3722.
[5] T. Morita, M. A. Perrella, M. E. Lee, S.
Kourembanas, Proc. Natl. Acad. Sci. USA
1995, 92, 1475.
[6] R. Motterlini, J. E. Clark, R. Foresti, P.
Sarathchandra, B. E. Mann, C. J. Green,
Circ. Res. 2002, 90, E17.
[7] J. E. Clark, P. Naughton, S. Shurey, C.
J. Green, T. R. Johnson, B. E. Mann, R.
Foresti, R. Motterlini, Circ. Res. 2003, 93,
E2.
[8] R. Foresti, J. Hammad, J. E. Clark, T.
R. Johnson, B. E. Mann, A. Friebe, C. J.
Green, R. Motterlini, Brit. J. Pharmacol.
2004, 142, 453.
[9] R. Alberto, K. Ortner, N. Wheatley, R.
Schibli, A. P. Schubiger, J. Am. Chem.
Soc. 2001, 123, 3135.
[10] R. Motterlini, P. Sawle, S. Bains, J.
Hammad, R. Alberto, R. Foresti, C. J.
Green, Faseb. J. 2004, 18.
Fig. 4.
11
B NMR of the hydrolysis of 3 → 1 (left) and the corresponding
1
H spectrum in the B-H region
(right)
